Skip to content

Eric Pauwels, Chief Business Officer at Ptc Therapeutics, sold PTCT on Jun 10, 2026

Data as of Oct 16

▼ SELL$1.3M17,566 shares at $75.00Eric Pauwels Chief Business OfficerPTCT Ptc Therapeutics, Inc.
Watch PTCT
Traded
Jun 10, 2026
Disclosed
Jun 12, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Eric Pauwels, Chief Business Officer at Ptc Therapeutics, sold PTCT on Jun 10, 2026TRADEDDISCLOSED
PTCTSimilar stocks (XLV — its sector index fund), rebased to PTCT's price on the disclosure day
PTCT since disclosure
−21.2%
after the sale
Similar stocks (XLV) since disclosure
+14.9%
XLV — its sector index fund

Change in closing price from Jun 12, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLEric Pauwels Chief Business OfficerPTCT Ptc Therapeutics, Inc.$278Kdisclosed Jun 12 · filed 2 days after the trade

See every trade on PTCT →